EAM
RNTX

Empery Asset Management’s Rein Therapeutics RNTX Stock Holding History

Empery Asset Management’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$386K Buy
+370,834
New +$449K 0.45% 19

Other funds holding RNTX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $863M AUM 30.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.97B AUM 32.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.87B AUM 24.49% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
RCG
Rock Creek Group Washington, District of Columbia $994M AUM 11.29% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return

Empery Asset Management's RNTX Position: Q2 2026 in Review

Empery Asset Management opened a new position in Rein Therapeutics (RNTX) in Q2 2026: 370,834 shares worth $386K. The stake represents 0.45% of the portfolio and ranks #19 among its holdings.

27 funds tracked by Wall St. Rank hold RNTX as of Q2 2026.

  • Empery Asset Management held 370,834 shares of Rein Therapeutics worth $386K as of Q2 2026.
  • Rein Therapeutics was a new Empery Asset Management position in Q2 2026.
  • Rein Therapeutics made up 0.45% of Empery Asset Management's portfolio in Q2 2026, its #19 holding.
  • 27 funds tracked by Wall St. Rank held Rein Therapeutics as of Q2 2026.

Based on Empery Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.